These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31167986)

  • 1. G Protein-Coupled Receptor 39 Agonist Improves Concanavalin A-Induced Hepatitis in Mice.
    Muneoka S; Goto M; Nishimura T; Enomoto K; Kadoshima-Yamaoka K; Tomimori Y
    Biol Pharm Bull; 2019 Aug; 42(8):1415-1418. PubMed ID: 31167986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.
    Goto M; Tanaka Y; Murakawa M; Kadoshima-Yamaoka K; Inoue H; Murafuji H; Nagahira A; Kanki S; Hayashi Y; Nagahira K; Ogata A; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Int Immunopharmacol; 2009 Oct; 9(11):1347-51. PubMed ID: 19671449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR39 agonist TC-G 1008 ameliorates IL-1β-induced chondrocyte senescence.
    Lu H; Wang D; Li H; Zhong J; Lin Y; Xu X; Wang B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2612-2617. PubMed ID: 31237151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
    Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
    Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
    Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
    Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
    Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
    Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential antidepressant-like properties of the TC G-1008, a GPR39 (zinc receptor) agonist.
    Młyniec K; Starowicz G; Gaweł M; Frąckiewicz E; Nowak G
    J Affect Disord; 2016 Sep; 201():179-84. PubMed ID: 27235821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
    Gao M; Zhang J; Liu G
    Liver Int; 2005 Aug; 25(4):904-12. PubMed ID: 15998443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice.
    Yamashiki M; Mase A; Arai I; Huang XX; Nobori T; Nishimura A; Sakaguchi S; Inoue K
    Clin Sci (Lond); 2000 Nov; 99(5):421-31. PubMed ID: 11052923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
    Li B; Sun R; Wei H; Gao B; Tian Z
    Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
    Li M; Liu GT
    World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.
    Lee KC; Lin HC; Huang YH; Hung SC
    J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice.
    Zhang H; Gong Q; Li JH; Kong XL; Tian L; Duan LH; Tong J; Song FF; Fang M; Zheng F; Xiong P; Tan Z; Gong FL
    Int Immunopharmacol; 2010 Jan; 10(1):79-85. PubMed ID: 19818415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
    Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
    Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumigaclavine C improves concanavalin A-induced liver injury in mice mainly via inhibiting TNF-alpha production and lymphocyte adhesion to extracellular matrices.
    Zhao Y; Liu J; Wang J; Wang L; Yin H; Tan R; Xu Q
    J Pharm Pharmacol; 2004 Jun; 56(6):775-82. PubMed ID: 15231043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats.
    Mohamed DI; Elmelegy AA; El-Aziz LF; Abdel Kawy HS; El-Samad AA; El-Kharashi OA
    Eur J Pharmacol; 2013 Dec; 721(1-3):35-42. PubMed ID: 24140572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled receptor 39 plays an anti-inflammatory role by enhancing IL-10 production from macrophages under inflammatory conditions.
    Muneoka S; Goto M; Kadoshima-Yamaoka K; Kamei R; Terakawa M; Tomimori Y
    Eur J Pharmacol; 2018 Sep; 834():240-245. PubMed ID: 30053407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation.
    Wolf AM; Wolf D; Rumpold H; Ludwiczek S; Enrich B; Gastl G; Weiss G; Tilg H
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13622-7. PubMed ID: 16174751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice.
    Shirin H; Bruck R; Aeed H; Hershkoviz R; Lider O; Kenet G; Avni Y; Halpern Z
    Liver; 1997 Dec; 17(6):275-80. PubMed ID: 9455732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.